DaVita(DVA)
$174.56+0.49 (+0.28%)
DVA
DaVita stock kpis
$174.56
At close:+0.49 (+0.28%)
Want to see DVA full AI Analyst Report?
Treatment Days
Indicates the total number of days treatments are provided, reflecting the company’s capacity utilization and potential revenue generation.
Treatment Days have been remarkably stable within a narrow, seasonal band, with modest Q1 softness and the early‑2026 dip more likely operational/seasonal noise (missed treatments, smaller Fresenius pickup) than secular patient loss. Management’s reconfirmed guidance and upgraded near‑term treatment growth suggest volumes are trending up, but stock upside will depend less on additional treatment days and more on margin drivers — revenue‑per‑treatment pressure, ACA mix headwinds, and cost control.
DVA Treatment Days
| Date | Treatment Days |
|---|---|
| Sep 30, 2026 | 79.20 |
| Jun 30, 2026 | 78.00 |
| Mar 31, 2026 | 76.50 |
| Dec 31, 2025 | 79.50 |
| Sep 30, 2025 | 79.00 |
| Jun 30, 2025 | 78.00 |
| Mar 31, 2025 | 76.70 |
| Dec 31, 2024 | 79.00 |
| Sep 30, 2024 | 79.00 |
| Jun 30, 2024 | 78.00 |
| Mar 31, 2024 | 78.00 |
| Dec 31, 2023 | 78.00 |
| Sep 30, 2023 | 79.00 |
| Jun 30, 2023 | 78.00 |
| Mar 31, 2023 | 77.00 |
| Dec 31, 2022 | 79.00 |
| Sep 30, 2022 | 79.00 |
| Jun 30, 2022 | 78.00 |
| Mar 31, 2022 | 77.00 |
| Dec 31, 2021 | 79.00 |
| Sep 30, 2021 | 79.00 |
| Jun 30, 2021 | 78.00 |
| Mar 31, 2021 | 77.00 |
| Dec 31, 2020 | 79.00 |
| Sep 30, 2020 | 79.00 |
| Jun 30, 2020 | 78.00 |
| Mar 31, 2020 | 77.60 |

